[Application of dot immunogold filtration assay in antibody detection for cysticercosis]

Z P Liu1, H Li, L Y Zhu

  • 1Institute of Parasitic Diseases, Chinese Academy of Preventive Medicine, Shanghai, 200025.

Insights

A new dot immunogold filtration assay effectively detects cysticercosis antibodies in patient serum. This diagnostic method shows high sensitivity and specificity, offering a promising tool for cysticercosis diagnosis.

Area of Science:

  • Medical Parasitology
  • Immunodiagnostics

Background:

  • Cysticercosis, a parasitic infection caused by the larval cysts of *Taenia solium*, poses a significant global health challenge.
  • Accurate and accessible diagnostic tools are crucial for effective disease management and control.

Purpose of the Study:

  • To develop and evaluate a dot immunogold filtration assay (DIFA) for detecting serum antibodies against cysticercosis.
  • To establish DIFA as a reliable method for a diagnostic kit for cysticercosis patients.

Main Methods:

  • The study utilized cyst fluid from *Taenia solium* cysticercus as the diagnostic antigen.
  • Dot immunogold filtration assay (DIFA) and enzyme-linked immunosorbent assay (ELISA) were employed to detect serum antibodies.
  • A total of 71 serum samples from cysticercosis patients, 90 from healthy individuals, and 20 from patients with other conditions were analyzed.

Main Results:

  • DIFA demonstrated a sensitivity of 90.1% and a specificity of 95.6%.
  • The assay showed high concordance with ELISA, with a coincidence rate of 94.4%.
  • Minimal cross-reactivity was observed, with only one positive result in a non-cysticercosis patient (brain tumor).

Conclusions:

  • The dot immunogold filtration assay (DIFA) presents a promising and effective method for diagnosing cysticercosis.
  • DIFA's high accuracy and specificity support its potential for use in diagnostic kits.
Abstract